Fatemeh Karami-Tehrani Selected Research

Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)

12/2012	Expression of cGMP-dependent protein kinase, PKGIα, PKGIβ, and PKGII in malignant and benign breast tumors.
4/2012	Induction of apoptosis by type Iβ protein kinase G in the human breast cancer cell lines MCF-7 and MDA-MB-468.
9/2011	Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fatemeh Karami-Tehrani Research Topics

Disease

13	Breast Neoplasms (Breast Cancer) 01/2018 - 06/2003
10	Neoplasms (Cancer) 07/2016 - 10/2005
3	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 10/2011
1	Triple Negative Breast Neoplasms 04/2016
1	Adenocarcinoma 12/2010
1	Ovarian Neoplasms (Ovarian Cancer) 12/2010
1	Carcinogenesis 12/2010
1	Breast Diseases (Breast Disease) 01/2010
1	Colonic Neoplasms (Colon Cancer) 07/2004
1	Carcinoma (Carcinomatosis) 07/2004

Drug/Important Bio-Agent (IBA)

4	Estrogen ReceptorsIBA 01/2018 - 06/2003
4	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2012 - 08/2004
3	shikoninIBA 01/2018 - 01/2015
3	EnzymesIBA 07/2016 - 02/2013
3	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 12/2012 - 09/2011
3	Protein Isoforms (Isoforms)IBA 12/2012 - 04/2012
3	IsoenzymesIBA 08/2012 - 10/2005
3	AndrogensIBA 03/2012 - 12/2010
3	Adenosine (Adenocard)FDA LinkGeneric 03/2012 - 08/2004
2	GuanosineIBA 04/2012 - 09/2011
2	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 10/2011 - 08/2004
2	Adenosine DeaminaseIBA 01/2010 - 10/2005
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	NaphthoquinonesIBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2016
1	Pharmaceutical PreparationsIBA 04/2016
1	HexokinaseIBA 04/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2015
1	Glucose (Dextrose)FDA LinkGeneric 04/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	trichostatin A (A 300)IBA 02/2013
1	theasinensin AIBA 02/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2013
1	Histone Deacetylase InhibitorsIBA 02/2013
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 08/2012
1	Cyclic GMPIBA 09/2011
1	Androstenedione (4 Androstene 3,17 dione)IBA 12/2010
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2010
1	Testosterone (Sustanon)FDA Link 12/2010
1	Hormones (Hormone)IBA 12/2010
1	Purinergic P1 Receptor AgonistsIBA 01/2007
1	ColforsinIBA 08/2004
1	IonsIBA 07/2004
1	Pentetic Acid (DTPA)FDA LinkGeneric 07/2004
1	Cell Surface ReceptorsIBA 07/2004
1	Chelating AgentsIBA 07/2004
1	ZincIBA 07/2004
1	AcidsIBA 07/2004
1	MetalsIBA 07/2004
1	Tamoxifen FDA LinkGeneric 06/2003